Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI)
· seekingalpha.com
Sanara MedTech delivered a strong Q1'26, with 19% revenue growth, 93%+ gross margins, and its first GAAP profit in years. Click for this analysis of SMTI stock.
Sanara MedTech ( SMTI ) reported a surprisingly strong Q1 2026, posting 19% revenue growth, gross margins above 93%, and its first GAAP profitable quarter in ye...